Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030

Roots Analysis has announced the addition of "Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030" report to its list of offerings.
 
 
Spread the Word
Listed Under

Tag:
Pharma

Industry:
Research

Location:
Chariton - Iowa - US

Subject:
Reports

CHARITON, Iowa - Sept. 11, 2020 - PRLog -- London

Roots Analysis has announced the addition of "Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030" report to its list of offerings.

The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to cater to the evolving needs. It is also worth highlighting that stakeholders engaged in this domain are actively undertaking initiatives to develop interventions for SARS-CoV-2 virus.

Key Market Insights

Presently, more than 80 players claim to offer services for antibody discovery

Over 90% of the aforementioned players provide services for hit generation, followed by those offering services for antibody humanization (58%). It is worth mentioning that five service providers claim to have the required expertise to serve as one-stop-shops for all the antibody discovery steps.

More than 120 companies offer antibody discovery platforms

It is worth highlighting that close to 180 technologies focused on antibody discovery are presently available in the market. Further, nearly 50% platforms use library-based methods to discover antibodies. Amongst these, phage display is currently the most widely used technique. This is followed by single cell-based methods (20%).

Partnership activity within this domain has grown at a CAGR of 18%, between 2015 and 2020

In the last five years, more than 400 agreements were inked related to antibody discovery, with the maximum activity being reported in 2018. Majority of partnership deals signed within this domain were licensing agreements (25%), product development and commercialization agreements (24%), and R&D agreements (18%).

Nearly USD 7 billion has been invested in the antibody discovery domain, during 2016-2020

The aforementioned amount was raised across more than 140 funding instances. It is important to mention that, in 2019-2020, over USD 2 billion was raised by antibody discovery service and platform providers across close to 40 instances. Majority of the funding in this year was acquired through venture capital rounds (42%), grants (20%), and instances of initial public offering (10%).

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

or email sales@rootsanalysis.com (mailto:sales@rootsanalysis.com?subject=Large%20Volume%20W...)

You may also be interested in the following titles:

1.      Antibody Contract Manufacturing Market, 2020 – 2030 (https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html)

2.       Antibody Drug Conjugates Market (5th Edition), 2019-2030

3.      Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com (mailto:Gaurav.Chaudhary@rootsanalysis.com?subject=Large%20Volume%20Wearable%20Injectors%20Market%20(4th%20Edition)-%20Press%20Release%20Query)

Contact
Roots Analysis
***@gmail.com
End
Email:***@gmail.com
Tags:Pharma
Industry:Research
Location:Chariton - Iowa - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Roots Analysis PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share